Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 926.00
-25.00 (-2.63%)
At close: Feb 20, 2025
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 143.06 billion as of February 21, 2025. Its market cap has increased by 506.16% in one year.
Market Cap
143.06B
Enterprise Value
133.40B
Revenue
44.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
926.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 143.06B, an increase of 1,697.61%. That is a compound annual growth rate of 281.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 143.06B | 51.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 213.05B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Lotus Pharmaceutical | 72.97B |
| Lumosa Therapeutics | 39.69B |
| Oneness Biotech | 38.96B |
| Polaris Group | 34.55B |
| Pegavision | 30.65B |
| Center Laboratories | 29.75B |